Skip to content

Evaluation of a Personalized Physical Activity Coaching Program in Parkinson's Disease

Evaluation of a Personalized Physical Activity Coaching Program in Parkinson's Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02816619
Acronym
APA-PARK
Enrollment
50
Registered
2016-06-28
Start date
2016-03-31
Completion date
2018-09-30
Last updated
2016-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Parkinson's disease, Physical activity, Physical exercise

Brief summary

There is growing interest for physical activity in Parkinson's disease in order to improve mobility and function of these patients. It seems from previous studies that difficulty, intensity and specificity of physical exercises are important parameters conditioning the effect of physical activity on cerebral plasticity and clinical improvement. Thus, the aim of this study is to evaluate the benefits of a Personalized Physical Activity coaching program, including scheduled and frequent follow up associated with progressive readaptation of exercise intensity depending on individual performances (during 3 months), versus free practice of physical activity in Parkinson's disease.

Detailed description

Type of study: a randomized, single-blind, parallel-group, controlled clinical trial. Number of centers: 1 (Clermont-Ferrand) Patients Patients eligible for inclusion will be randomized to one of the two groups: * APA + : patients will beneficiate of Personalized Physical Activity coaching program during 3 months (1 hour, twice by week, during 3 months) * APA- : patients will do free practice of physical activity during 3 months. Study Performance Patients will be evaluated 3 times : at J0 (baseline, V1), 3 months after Personalized Physical Activity coaching program (J0+3M, V2), and 3 months after the end of the Personalized Physical Activity coaching program (J0+6M) V1: * Signature of an informed consent form. * Demographic and clinical characteristics (sex, age, disease duration, treatments). V1, V2, V3 * Neurological evaluation (Unified Parkinson Disease Rating Scale part III score) * Evaluation of quality of life (Parkinson's Disease Questionnaire 39-item version (PDQ-39), participation to Daily life activities (Lawton and Brody Activities of Daily Living scale (IADL questionnaire25) * Evaluation of performances for specific tests for balance (stabilometry), muscular strength (isometry) * Evaluation of cardiorespiratory function (VO2pic et 6 min Walk Test) * Evaluation of body composition (lean body mass/fat mass) with DEXA. * Dropout rates at V2 and V3 * Evaluation of the activity with the eMOUVE application in a subgroup of patients.

Interventions

BEHAVIORALPersonalized Physical Activity coaching program
BEHAVIORALFree practice of physical activity

Sponsors

Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques
CollaboratorOTHER
UFR STAPS
CollaboratorUNKNOWN
University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Clinical criteria for Parkinson's disease * Men or women aged from 18 to 80 years old. * Social security coverage. * Ability to provide informed consent.

Exclusion criteria

* neurological disease other than Parkinson's disease * severe depression (Beck Depression Inventory\>37) or psychiatric comorbidities (UPDRS I ) * significant cognitive impairment (MoCA\<24) * orthopedic impairment with functional restriction * contraindication to physical exercise

Design outcomes

Primary

MeasureTime frame
Change from baseline of the Unified Parkinson Disease Rating Scale part III scoreat +3months

Secondary

MeasureTime frame
Change from baseline of the Lawton and Brody Activities of Daily Living scale scoreat +3months
Change from baseline of the percentage of sedentarity, mild, moderate and intense activity using the eMOUVE applicationat +3months
Change from baseline of percentage of sedentarity, mild, moderate and intense activity using the eMOUVE applicationat + 6 months
Change from baseline of balancing abilities measured by stabilometryat +3months
Change from baseline of muscular strength measured with isometric testat +3months
Change from baseline of Parkinson's Disease Questionnaire 39-item version scoreat +3months
Change from baseline of the 6 min Walking Test scoreat +3 months
Change from baseline of fat and lean body mass measured by DEXAat +3 months.
Change from baseline fat and lean body mass measured by DEXAat +6 months.
dropout ratesat +3 months
Change from baseline of VO2picat +3months

Countries

France

Contacts

Primary ContactPatrick LACARIN
placarin@chu-clermontferrand.fr04 73 75 11 95

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026